I. Hodish

发表

Challenges in Insulin Therapy for Type 2 Diabetes

I. Hodish, 2021, Diabetes Therapy.

Transcription-controlled gene therapy against tumor angiogenesis.

I. Barshack, D. Harats, D. Wallach, 2004, The Journal of clinical investigation.

Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK

I. Barshack, D. Harats, D. Ben-Shushan, 2009, Cancer biology & therapy.

Endothelial-targeted Gene Transfer of Hypoxia-inducible Factor-1α Augments Ischemic Neovascularization Following Systemic Administration.

I. Barshack, D. Harats, E. Feige, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth

P. Arvan, Ming Liu, L. Haataja, 2010, Trends in Endocrinology & Metabolism.

Type 2 diabetes specialty clinic model for the accountable care organization era.

M. Funnell, I. Hodish, S. Lathkar-Pradhan, 2017, Journal of diabetes and its complications.

In Vivo Misfolding of Proinsulin Below the Threshold of Frank Diabetes

P. Arvan, Ming Liu, L. Haataja, 2011, Diabetes.

Histological insights into the pathogenesis of post‐Roux‐en‐Y hyperinsulinaemic hypoglycaemia

T. Giordano, R. Lash, I. Hodish, 2014, Diabetic medicine : a journal of the British Diabetic Association.

Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter.

I. Barshack, D. Harats, D. Ben-Shushan, 2005, Cancer letters.

Long-term effects of pegvisomant in patients with acromegaly

A. Barkan, I. Hodish, 2008, Nature Clinical Practice Endocrinology &Metabolism.

Temporary Reductions in Insulin Requirements Are Associated with Hypoglycemia in Type 2 Diabetes.

R. Harper, E. Bashan, I. Hodish, 2018, Diabetes technology & therapeutics.

THE EFFICACY AND SAFETY OF CO-ADMINISTRATION OF SITAGLIPTIN WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES AT HOSPITAL DISCHARGE.

G. Umpierrez, K. Dungan, R. Gianchandani, 2018, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect

I. Barshack, D. Harats, D. Ben-Shushan, 2008, Cancer Gene Therapy.

Adrenal Lymphangioma Masquerading as a Catecholamine Producing Tumor

I. Hodish, Lindsay A. Schmidt, A. Moraitis, 2015, Case reports in endocrinology.

Specific Induction of Tumor Neovasculature Death by Modified Murine PPE-1 Promoter Armed with HSV-TK

I. Barshack, D. Harats, S. Greenberger, 2008, Pathobiology.

Effect of Elevated Homocysteine Levels on Clinical Restenosis following Percutaneous Coronary Intervention

D. Freimark, H. Hod, V. Guetta, 2002, Cardiology.

Insulin therapy, weight gain and prognosis

I. Hodish, 2018, Diabetes, obesity & metabolism.

Challenging the 50‐50 rule for the basal‐bolus insulin ratio in patients with type 2 diabetes who maintain stable glycaemic control

R. Harper, E. Bashan, I. Hodish, 2022, Diabetes, obesity and metabolism.

For debate; pharmacological priorities in advanced type 2 diabetes.

I. Hodish, 2019, Journal of diabetes and its complications.

Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial

D. Kruger, R. Bergenstal, A. Bhargava, 2019, The Lancet.

Insulin therapy for type 2 diabetes – are we there yet? The d-Nav® story

I. Hodish, 2018, Clinical Diabetes and Endocrinology.

Dynamics in insulin requirements and treatment safety.

R. Harper, E. Bashan, I. Hodish, 2016, Journal of diabetes and its complications.

A novel approach to optimise glycaemic control in insulin users

R. Harper, E. Bashan, I. Hodish, 2015, BMJ Case Reports.

Can a tool that automates insulin titration be a key to diabetes management?

Eran Bashan, R. Bergenstal, Mary L. Johnson, 2012, Diabetes technology & therapeutics.

Are glucose readings sufficient to adjust insulin dosage?

W. Herman, E. Bashan, I. Hodish, 2011, Diabetes technology & therapeutics.

Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial.

G. Umpierrez, Limin Peng, K. Dungan, 2017, The lancet. Diabetes & endocrinology.

Location of ectopic adrenocortical hormone‐secreting tumors causing Cushing's syndrome in the paranasal sinuses

T. Giordano, D. Schteingart, M. Starkman, 2009, Head & neck.

Proinsulin maturation, misfolding, and proteotoxicity

P. Arvan, Ming Liu, C. Rhodes, 2007, Proceedings of the National Academy of Sciences.

Reiter's syndrome after intravesical Bacillus Calmette-Guérin therapy for bladder cancer.

D. Olchovsky, D. Ezra, I. Hodish, 2000, The Israel Medical Association journal : IMAJ.

Insulin Therapy for Pre-Hyperglycemic Beta-Cell Endoplasmic Reticulum Crowding

I. Hodish, A. Absood, A. Zaki, 2013, PloS one.

Misfolded Proinsulin Affects Bystander Proinsulin in Neonatal Diabetes*

P. Arvan, Ming Liu, R. Holz, 2009, The Journal of Biological Chemistry.

Can the current healthcare delivery model cope with advanced type 2 diabetes?

I. Hodish, Israel Hodish, 2015, Journal of diabetes and its complications.

Frequent insulin dosage adjustments based on glucose readings alone are sufficient for a safe and effective therapy.

E. Bashan, I. Hodish, 2012, Journal of diabetes and its complications.